i didn't buy enough and sold 2/3 of the position likely too soon. and to add insult to injury, my better half ranted that i always sell too soon and made me swear not to sell anymore before her price target of $500/share- curious how that'll go (was she interested in the profit we made in less than 24 hrs? - no). where does the anger come from you might ask- she still holds a grudge that she convinced me to buy a pile of TSLA in 2016 which i promptly sold when Musk claimed he had "funding secured". oh well- DWAC at least dulled the pain of seeing OCUL dump 30% today... gotta love the market
ABB price target raised to CHF 28.10 from CHF 27.50 at Morgan Stanley 12:37 ABB Morgan Stanley analyst Ben Uglow raised the firm's price target on ABB to CHF 28.10 from CHF 27.50 and keeps an Underweight rating on the shares.
SewerAI announces Bentley Systems participates in $1.5M venture round 11:00 BSY SewerAI announced that Bentley Systems participated in SewerAI's $1.5M venture round through the Bentley iTwin Ventures Fund. Bentley joined Burnt Island Ventures, Builders VC, and EPIC Ventures among others in this round. SewerAI uses artificial intelligence and computer vision to inspect, identify and analyze sewer infrastructure defects. SewerAI's AI, cloud-based software AutoCode significantly enhances and accelerates sewer infrastructure inspections.
Sony announces State of Play event on October 27 10:23 SONY Imax initiated with an Overweight at Wells Fargo 06:23 IMAX Wells Fargo analyst Steven Cahall initiated cover
bad day to have bad news. > Bicycle Therapeutics (BCYC) estimated short interest peaked at 124.7% on Tuesday and pulled in to 110.7% by the end of Thursday, but the weekly increase still amounted to a 50 percentage point increase from last Thursday’s 61%. Bears have been piling on to the stock since the stock staged an abrupt upward reversal following the release of clinical trial data on October 7, fanning the debate over the potential of its BT5528 and BT8009 programs. Shares of Bicycle Therapeutics were down 5.6% in the five-day period covered. Estimated short interest in National Beverage (FIZZ) nudged up to a one-month high of 25.2% before ending the week up four percentage points at 24.6%, while its days-to-cover ratio rose over 20% to 5.4. Notably, the increase in the short position comes amid relatively slower trading volume and volatility, with the stock down by just about 1.0% in the five-day period covered.
Penn, Rush Street share solid despite 'disciplined spend,' says Craig-Hallum 13:33 DKNG, CZR, MGM, PENN, RSI The three most important states have reported September gaming data with "strong trends," Craig-Hallum analyst Ryan Sigdahl tells investors in a research note. The analyst, however, sees a "clear deviation happening in spend." DraftKings (DKNG) and Caesars (CZR) continue to aggressively spend and focus on user growth, with FanDuel and MGM (MGM) "a bit more moderated" while maintaining leadership in online sports betting and internet gaming, respectively, Sigdahl says. Meanwhile, Penn National Gaming (PENN) and Rush Street Interactive (RSI) are reporting solid market share despite more "disciplined spend," according to the analyst. RSI/RSI- Rush Street Interactive $20.68 -0.52(-2.45%)
i'm too burnt out to look into it. fda said their eye insert didn't meet the endpoint. i'm hoping it's not the same insert that boosted their sales by 6x. i'll hang onto it for now until i figure that detail out.
OCUL dumped because the OTX-CSI trial for dry eyes failed. but the money maker that drove sales 6x higher is dextenza. i'm adding more OCUL today.